Johnson & Johnson has announced yet another Tylenol recall due to a musty moldy odor linked to a trace chemical.
The company’s McNeil Consumer Healthcare unit is recalling more than 60,000 bottles of Tylenol Extra Strength Caplets made in February 2009 and distributed in the U.S.
The chemical, known as TBA, is a byproduct of a chemical preservative sometimes used on shipping pallets. Besides causing an unpleasant odor, TBA has been associated with temporary and non-serious gastrointestinal symptoms.
Since September 2009, New Brunswick, N.J.-based Johnson & Johnson has had about two dozen recalls of prescription and nonprescription medicines, replacement hips, contact lenses and diabetes test strips, including tens of millions of bottles of children’s and adult Tylenol and Motrin.
Was this article valuable?
Here are more articles you may enjoy.
Judge Upholds $243M Verdict Against Tesla Over Fatal Autopilot Crash
Building Fortification And The Role of The Insurance Industry
Walmart to Pay $100 Million to Settle FTC Case on Driver Wages
Carriers See Higher Claims Severity Amid Medical, Social Inflation and Growth in AI‑Generated Fraud